Insulin-Like Growth Factor Binding Protein-Related Protein 1 Mediates VEGF-Induced Proliferation, Migration and Tube Formation of Retinal Endothelial Cells

REFERENCES

• Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389–395.
   PubMed Web of Science ®Google Scholar
• Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation. Nature. 2000;407:242–248.
   PubMed Web of Science ®Google Scholar
• Engerman RL. Pathogenesis of diabetic retinopathy. Diabetes. 1989;38:1203–1206.
   PubMed Web of Science ®Google Scholar
• Fielder AR, Reynolds JD. Retinopathy of prematurity: Clinical aspects. Semin Neonatol. 2001;6:461–475.
   PubMedGoogle Scholar
• Aiello LP. Perspectives on diabetic retinopathy. Am J Ophthalmol. 2003;136:122–135.
   PubMed Web of Science ®Google Scholar
• Dorrell M, Uusitalo-Jarvinen H, Aguilar E, et al. Ocular neovascularization: Basic mechanisms and therapeutic advances. Surv Ophthalmol. 2007;52 suppl 1:S3–S19.
   Google Scholar
• Castellon R, Hamdi HK, Sacerio I, et al. Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp Eye Res. 2002;74:523–535.
   PubMed Web of Science ®Google Scholar
• Simó R, Carrasco E, García-Ramírez M, et al. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev. 2006;2:71–98.
   PubMedGoogle Scholar
• Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev. 1999;20:761–787.
   PubMed Web of Science ®Google Scholar
• Burger AM, Leyland-Jones B, Banerjee K, et al. Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer. Eur J Cancer. 2005;41:1515–1527.
   PubMed Web of Science ®Google Scholar
• Burger AM, Zhang X, Li H, et al. Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas. Oncogene. 1998;16:2459–2467.
   PubMed Web of Science ®Google Scholar
• Sprenger CC, Damon SE, Hwa V, et al. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer. Cancer Res. 1999;59:2370–2375.
   PubMed Web of Science ®Google Scholar
• Akaogi K, Okabe Y, Sato J, et al. Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells. Proc Natl Acad Sci U S A. 1996;93:8384–8389.
   PubMed Web of Science ®Google Scholar
• Kishibe J, Yamada S, Okada Y, et al. Structural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/angiomodulin that induces cord-like structures to ECV-304 human carcinoma cells. J Biol Chem. 2000;275:15321–15329.
   PubMedGoogle Scholar
• Yamauchi T, Umeda F, Masakado M, et al. Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochem J. 1994;303:591–598.
   PubMedGoogle Scholar
• St Croix B, Rago C, Velculescu V, et al. Genes expressed in human tumor endothelium. Science. 2000;289:1197–1202.
   PubMed Web of Science ®Google Scholar
• Degeorges A, Wang F, Frierson Jr HF, et al. Distribution of IGFBP-rP1 in normal human tissues. J Histochem Cytochem. 2000;48:747–754.
   PubMedGoogle Scholar
• Ono Y, Hashimoto T, Umeda F, et al. Expression of prostacyclin-stimulating factor, a novel protein, in tissues of Wistar rats and in cultured cells. Biochem Biophys Res Commun. 1994;202:1490–1496.
   PubMedGoogle Scholar
• Swisshelm K, Ryan K, Tsuchiya K, et al. Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc Natl Acad Sci U S A. 1995;92:4472–4476.
   PubMed Web of Science ®Google Scholar
• Lou DA, Hu FN. Co-distribution of Von Willebrand factor and fibronectin in cultured rhesus endothelial cells. Histochem J. 1987;19:431–438.
   PubMedGoogle Scholar
• Lou DA, Hu FN. Specific antigen and organelle expression of a long-term rhesus endothelial cell line. In Vitro Cell Dev Biol. 1987;23:75–85.
   PubMedGoogle Scholar
• Yang H, Chaum E. A reassessment of insulin-like growth factor binding protein gene expression in the human retinal pigment epithelium. J Cell Biochem. 2003;89:933–943.
   PubMedGoogle Scholar
• Haugk KL, Wilson HM, Swisshelm K, et al. Insulin-like growth factor (IGF)-binding protein-related protein-1: An autocrine/paracrine factor that inhibits skeletal myoblast differentiation but permits proliferation in response to IGF. Endocrinology. 2000;141: 100–102.
   PubMedGoogle Scholar
• Wajapeyee N, Serra RW, Zhu X, et al. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 2008;132:363–374.
   PubMed Web of Science ®Google Scholar
• Skeie JM, Mullins RF. Elastin-mediated choroidal endothelial cell migration: Possible role in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:5574–5580.
   PubMedGoogle Scholar
• You JJ, Yang CH, Chen MS, et al. Cysteine-rich 61, a member of the CCN family, as a factor involved in the pathogenesis of proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009;50:3447–3455.
   PubMedGoogle Scholar
• Gupta K, Kshirsagar S, Li W, et al. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res. 1999;247:495–504.
   PubMed Web of Science ®Google Scholar
• Wilson HM, Birnbaum RS, Poot M, et al. Insulin-like growth factor binding protein-related protein 1 inhibits proliferation of MCF-7 breast cancer cells via a senescence-like mechanism. Cell Growth Difer. 2002;13:205–213.
   PubMedGoogle Scholar
• Mutaguchi K, Yasumoto H, Mita K, et al. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer. Cancer Res. 2003;63:7717–7723.
   PubMed Web of Science ®Google Scholar
• Ruan WJ, Lin J, Xu EP, et al. IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1. J Zhejiang Univ Sci B. 2006;7:929–932.
   PubMedGoogle Scholar
• Chen Y, Pacyna-Gengelbach M, Ye F, et al. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer. J Pathol. 2007;211:431–438.
   PubMedGoogle Scholar
• Mercer KE, Pritchard CA. Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim Biophys Acta. 2003;1653:25–40.
   PubMed Web of Science ®Google Scholar
• Chang F, Steelman LS, Shelton JG, et al. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway. Int J Oncol. 2003;22:469–480.
   PubMed Web of Science ®Google Scholar
• Hüser M, Luckett J, Chiloeches A, et al. MEK kinase activity is not necessary for Raf-1 function. EMBO J. 2001;20:1940–1951.
   PubMed Web of Science ®Google Scholar
• Garnett MJ, Marais R. Guilty as charged: B-Raf is a human oncogene. Cancer Cell. 2004;6:313–319.
   PubMed Web of Science ®Google Scholar
• Galabova-Kovacs G, Matzen D, Piazzolla D, et al. Essential role of B-Raf in ERK activation during extraembryonic development. Proc Natl Acad Sci U S A. 2006;103:1325–1330.
   PubMedGoogle Scholar
• Baxter RC, Binoux MA, Clemmons DR, et al. Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology. 1998;139:4036.
   PubMedGoogle Scholar
• Yamanaka Y, Wilson EM, Rosenfeld RG, et al. Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J Biol Chem. 1997;272:30729–30734.
   PubMed Web of Science ®Google Scholar
• Lu M, Amano S, Miyamoto K, et al. Insulin-induced vascular endothelial growth factor expression in retina. Invest Ophthalmol Vis Sci. 1999;40:3281–3286.
   PubMed Web of Science ®Google Scholar
• Poulaki V, Qin W, Joussen AM, et al. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1α and VEGF. J Clin Invest. 2002;109:805–815.
   PubMed Web of Science ®Google Scholar
• Kondo T, Vicent D, Suzuma K, et al. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest. 2003;111:1835–1842.
   PubMed Web of Science ®Google Scholar